During Monday's early US trading session, shares of regenerative medicine company Avita Medical Ltd. (RCEL) surged 35% following the company's announcement that its RECELL GO device received CE certification, initially driving the stock up 10%. The device is designed to help treat acute traumatic injuries and will expand Avita Medical Ltd.'s business operations in the European medical market.